Shanghai Titan Scientific Co., Ltd. (SHA:688133)
China · Delayed Price · Currency is CNY 17.76
-0.03 (-0.17%)
Nov 13, 2026, 9:40 AM CST
Shanghai Titan Scientific Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 751.27 | 881.47 | 985.98 | 1,051 | 1,390 | 675.95 |
Trading Asset Securities | 30.18 | 34.17 | 40.26 | - | - | 11 |
Cash & Short-Term Investments | 781.44 | 915.65 | 1,026 | 1,051 | 1,390 | 686.95 |
Cash Growth | -7.78% | -10.78% | -2.31% | -24.43% | 102.36% | -21.40% |
Accounts Receivable | 892.71 | 809.08 | 834.19 | 871.02 | 705.77 | 594.01 |
Other Receivables | 13.37 | 14.08 | 15.08 | 16.28 | 18.67 | 21.3 |
Receivables | 906.09 | 823.16 | 849.27 | 887.29 | 724.44 | 615.31 |
Inventory | 1,080 | 1,056 | 1,064 | 989.88 | 850.5 | 590.65 |
Other Current Assets | 207.18 | 180.34 | 199.27 | 176.65 | 173.78 | 196.54 |
Total Current Assets | 2,974 | 2,975 | 3,139 | 3,104 | 3,139 | 2,089 |
Property, Plant & Equipment | 1,289 | 1,278 | 1,015 | 753.75 | 384.25 | 212.27 |
Long-Term Investments | 125.03 | 115.02 | 106.45 | 103.24 | 78.66 | 47.58 |
Goodwill | 123.07 | 123.07 | 152.62 | 100.74 | 100.74 | 100.74 |
Other Intangible Assets | 182.41 | 198.54 | 209.93 | 191.57 | 192.5 | 87 |
Long-Term Deferred Tax Assets | 42.31 | 39.69 | 27.19 | 25.22 | 15.37 | 10.69 |
Long-Term Deferred Charges | 88.53 | 103.05 | 113.28 | 54.25 | 23.45 | 31.77 |
Other Long-Term Assets | 64.39 | 34.62 | 85.04 | 55.19 | 37.8 | 13.85 |
Total Assets | 4,889 | 4,867 | 4,849 | 4,388 | 3,972 | 2,593 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 171.81 | 167.96 | 198.3 | 165.05 | 153.52 | 155.53 |
Accrued Expenses | 22.59 | 85.37 | 78.69 | 72.36 | 64.09 | 45.19 |
Short-Term Debt | 990.02 | 1,016 | 984.57 | 728.38 | 509.11 | 341.18 |
Current Portion of Long-Term Debt | 140.8 | 148.72 | 83.99 | 55.82 | 30.01 | 0.84 |
Current Portion of Leases | - | 10.6 | 13.16 | 14.85 | 10.65 | 6.39 |
Current Income Taxes Payable | 59.5 | 1.81 | 1.08 | 2.32 | 11.05 | 21.5 |
Current Unearned Revenue | 62.26 | 45.6 | 55.64 | 72.65 | 73.5 | 76.52 |
Other Current Liabilities | 159.58 | 53.3 | 40.92 | 32.56 | 36.71 | 201.31 |
Total Current Liabilities | 1,607 | 1,529 | 1,456 | 1,144 | 888.65 | 848.45 |
Long-Term Debt | 422.93 | 416.38 | 434.38 | 322.38 | 270.25 | 108.28 |
Long-Term Leases | 38.91 | 46.11 | 25.52 | 34.51 | 23.87 | 8.11 |
Long-Term Unearned Revenue | 15.13 | 20.82 | 17.24 | 22.01 | 16.44 | 2.39 |
Long-Term Deferred Tax Liabilities | 19.39 | 20.45 | 14.49 | 15.25 | 5.73 | 4.69 |
Other Long-Term Liabilities | 8 | 8 | 30 | - | - | 5.39 |
Total Liabilities | 2,111 | 2,041 | 1,978 | 1,538 | 1,205 | 977.3 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 164.44 | 164.44 | 164.44 | 117.97 | 84.07 | 76.25 |
Additional Paid-In Capital | 2,101 | 2,091 | 2,083 | 2,137 | 2,155 | 1,136 |
Retained Earnings | 424.56 | 485.67 | 528.1 | 526.95 | 473.81 | 363.73 |
Comprehensive Income & Other | 10.22 | 12.21 | 10.55 | 9.1 | 6.51 | -0.18 |
Total Common Equity | 2,700 | 2,753 | 2,786 | 2,791 | 2,720 | 1,576 |
Minority Interest | 78.36 | 72.51 | 84.57 | 59.57 | 46.97 | 40.06 |
Shareholders' Equity | 2,778 | 2,826 | 2,871 | 2,850 | 2,767 | 1,616 |
Total Liabilities & Equity | 4,889 | 4,867 | 4,849 | 4,388 | 3,972 | 2,593 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,593 | 1,638 | 1,542 | 1,156 | 843.89 | 464.79 |
Net Cash (Debt) | -811.22 | -722.08 | -515.37 | -105.38 | 546.23 | 222.16 |
Net Cash Growth | - | - | - | - | 145.87% | -67.67% |
Net Cash Per Share | -4.86 | -4.44 | -3.20 | -0.64 | 3.53 | 1.49 |
Filing Date Shares Outstanding | 167.15 | 164.44 | 164.44 | 165.16 | 164.78 | 149.45 |
Total Common Shares Outstanding | 167.15 | 164.44 | 164.44 | 165.16 | 164.78 | 149.45 |
Working Capital | 1,368 | 1,445 | 1,683 | 1,960 | 2,250 | 1,241 |
Book Value Per Share | 16.15 | 16.74 | 16.94 | 16.90 | 16.51 | 10.55 |
Tangible Book Value | 2,394 | 2,432 | 2,424 | 2,498 | 2,426 | 1,388 |
Tangible Book Value Per Share | 14.32 | 14.79 | 14.74 | 15.13 | 14.73 | 9.29 |
Buildings | - | 1,014 | 260.37 | 259.91 | 56.02 | 54.55 |
Machinery | - | 423.9 | 308.26 | 218.58 | 114.22 | 90.82 |
Construction In Progress | - | 0.12 | 561.88 | 330.12 | 254.89 | 113.47 |